Orbit CEO Neil Butt and Business Developer Simon Bushell will be the 2024 BioEurope conference in Stockholm, Sweden from November 4-6th, 2024. They would be delighted to talk about how our platforms empower big pharma and small biotech alike in their peptide discovery efforts.

Orbit CEO, Neil Butt will be attending the 2024 European Association for Nuclear Medicine Congress in Hamburg, Germany from October 19th to 23rd. Come learn more about how Orbit is helping leading radiopharmaceutical companies discover novel peptide conjugates for radionuclide delivery.

Simon Bushell, will be attending the 37th European Peptide Symposium, to be held in August in Florence, Italy. This year the event is merged with the 14th International Peptide Symposium, and promises to be the biggest peptide event of the year.

The Boulder Peptide Symposium continues to be the premier peptide discovery and development meeting of the year. Orbit Discovery will again be attending this year's event in September.

Orbit Discovery CEO, Neil Butt, will be attending the 3rd Annual Targeted Radiopharmaceuticals Summit in San Diego, CA from July 30th to August 1st.

Our Business Developer, Jordan Palfrey is looking forward to attending the 3rd GPCR-Targeted Drug Discovery Summit in Boston from March 5-7, 2024. Please connect with Jordan if you're interested in discovering GPCR therapeutic peptide hits using Orbit's direct-to-cell high throughput functional screening capabilities. We'd be delighted to learn more and discuss how we can help!

We are looking forward to the upcoming JPM meeting in San Francisco.

Neil Butt (CEO) of Orbit Discovery will be attending the Peptide Symposium in Boulder Col0rado (7th - 10th November) . If you have an interest in peptide and/or small scaffold discovery, be it for targeting cells, PROTACS and Molecular Glues or for functional screening in identifying GPCR agonists, please connect via info@orbitdiscovery.com. We look forward to meeting you in Boulder

Dr Jordan Palfry will be attending TIDES Europe between the 16th and 18th November. If you have an interest in peptide discovery, be it for targeting cells, PROTACS and molecular Glues or for functional screening in identifying GPCR agonists, please connect via info@orbitdiscovery.com. We look forward to meeting you  in Boulder

Orbit Discovery will be attending the Partnering event at BIO International. If you have an interest in peptide discovery, be it for targeting cells or for functional activity, please connect via the BIO partnering system. We look forward to meeting you face to face in San Diego

Orbit Discovery will be attending Biotrinity between the 26th and 27th April . If you wish to hear more about our unique peptide discovery service platform we will be delighted to hear from you to arrange a  meeting

Dr Caroline Woffindale and Dr Neil Butt  will be attending TIDES between the 9th and 12th May. Caroline will be presenting a poster entitled, <strong>Generating Novel Peptide Leads against the Melanocortin 4 Receptor using the Orbit Display Platform. </strong>If you wish to understand how we identified peptides to this GPCR,  we will be delighted to hear from you to arrange a meeting

Looking for therapeutic peptides? Targeting peptide screening, GPCR peptide screening, Cell surface screening, Protacs – GPCRs - Target Drug Discovery Summit March 22–24, 2022 and welcome the opportunity to meet.

Looking for therapeutic peptides?

Orbit Discovery will be attending the TIDES between the 9th and 13th May 2022. If you wish to hear more about our unique peptide discovery service platform, functional screening capabilities and cell based screening we will be delighted to arrange a meeting with our CEO, Dr Neil Butt and CTO, Anthony Pitt.

Orbit Discovery will be attending BIO in San Diego between the 13th and 17th June 2022. If you wish to hear more about our unique peptide discovery service platform, functional screening capabilities and cell based screening we will be delighted to arrange a meeting with our CEO, Dr Neil Butt and CTO, Anthony Pitt. We look forward to seeing you all in San Diego

Orbit Discovery will be attending the Biotech Showcase in San Francisco between the 10th and 14th January 2022. If you wish to hear more about our unique peptide discovery service platform, functional screening capabilities and cell based screening we will be delighted to arrange a meeting with our CEO, Dr Neil Butt.

Orbit Discovery will be attending BIO Europe between the 25th and 28th October 2021. If you wish to hear more about our unique peptide discovery service platform we will be delighted to hear from you to arrange a virtual meeting